Adaptive speed control algorithms and controllers for optimizing flow in ventricular assist devices

    公开(公告)号:US11241572B2

    公开(公告)日:2022-02-08

    申请号:US16552102

    申请日:2019-08-27

    申请人: TC1 LLC

    摘要: Method and systems control a rotational speed of a blood pump during ventricular diastole. A method includes controlling a blood pump in accordance with a first segment operational mode. A controller monitors the blood flow rate through the blood pump. The controller determines, based on the blood flow rate, whether continued controlling of the blood pump per the first segment operational mode would result in the blood flow rate through the blood pump being less than a target minimum blood flow rate. In response to a determination that continued controlling of the blood pump per the first segment operational mode would result in the blood flow rate through the blood pump being less than the target minimum blood flow rate, the controller controls the rotational speed of the blood pump so that the blood flow rate through the blood pump is approximate to the target minimum blood flow rate.

    BLOOD CIRCULATION SYSTEM
    6.
    发明申请

    公开(公告)号:US20220023523A1

    公开(公告)日:2022-01-27

    申请号:US17498422

    申请日:2021-10-11

    摘要: A blood circulation system that can be connected to a human body is provided. The system may include a roller pump, a blood removal line through which blood removed from the human body flows to the roller pump, a blood transfer line that transfers blood, which is sent from the roller pump, to the human body, means for measuring a blood removal rate provided in the blood removal line to measure a blood removal rate parameter of blood flowing through the blood removal line and a control unit, wherein the control unit is programmed to control a blood transfer rate of the roller pump by controlling a rotational speed of the roller pump with a control signal, such that a transfer rate of blood flowing through the blood transfer line is synchronized with a removal rate calculated from the blood removal rate parameter.

    INDWELLING HYPER-DIMENSIONAL CARDIAC PHYSIOLOGIC DATA LOGGING AND TRANSMISSION SYSTEM AND METHOD OF DOING BUSINESS

    公开(公告)号:US20210290934A1

    公开(公告)日:2021-09-23

    申请号:US17260267

    申请日:2019-07-17

    申请人: VIADERM LLC

    摘要: A system to optimize the operation of counter pulsatile cardiac assist devices includes a collection of intracorporeal and extracorporeal physiologic sensors that generate data. A control system in electrical communication with the collection of intracorporeal and extracorporeal physiologic sensors generates control signals for the counter pulsatile cardiac assist device based on a counter pulsating aortic pumping element based on the data. A low power transmitter is in electrical communication with the collection of sensors and the control system and sends the generated data and the control signals to an external computer for aggregation and analysis. The analysis is based on a set of inputs from an implanted counter pulsatile cardiac assist devices.

    IMPLANTABLE PUMP SYSTEM HAVING A RECTANGULAR MEMBRANE

    公开(公告)号:US20210170160A1

    公开(公告)日:2021-06-10

    申请号:US17179961

    申请日:2021-02-19

    申请人: CorWave SA

    摘要: An implantable pump system is provided, including an implantable blood pump suitable for use as a partial support assist device, the system further including an extracorporeal battery and a controller coupled to the implantable pump, and a programmer selectively periodically coupled to the controller to configure and adjust operating parameters of the implantable pump. The implantable pump includes a flexible membrane coupled to an electromagnetic actuator including a magnetic assembly and electromagnetic assembly, so that when the electromagnetic assembly is energized, the electromagnetic assembly causes wavelike undulations to propagate along the flexible membrane to propel blood through the implantable pump. The controller may be programmed by a programmer to operate at frequencies and duty cycles that mimic physiologic flow rates and pulsatility while operating in an efficient manner that avoids thrombus formation, hemolysis and/or platelet activation.